Table: begin end state 1 14 cytoplasmic 15 39 transmembrane 40 44 non-cytoplasmic 45 71 transmembrane 72 108 cytoplasmic 109 132 transmembrane 133 145 non-cytoplasmic 146 167 transmembrane 168 168 cytoplasmic 169 191 transmembrane 192 202 non-cytoplasmic 203 221 transmembrane 222 256 cytoplasmic 257 280 transmembrane 281 317 non-cytoplasmic 318 339 transmembrane 340 356 cytoplasmic 357 384 transmembrane 385 389 non-cytoplasmic 390 407 transmembrane 408 413 cytoplasmic 414 433 transmembrane 434 470 non-cytoplasmic 471 491 transmembrane 492 503 cytoplasmic
Input: >Ac3H11_1732 MDLINNLSLGFGVAFTFQNLIYCFVGCLLGTLIGVLPGIGPVATIAMLLPATYALPPVAA LIMLAGIYYGAQYGGSTTAILVNLPGESSSVVTVIDGYQMARKGRAGPALAAAGLGSFFA GCVGTLILAAFAPPLTEVAFKFGPAEYFSLMVLGLIGAVVLASGSLLKAVGMIVLGLLMG LVGTDVNSGVARFSFDIPELTDGIGFVTIAMGVFGYGEIIANLSRPDEDREVFTAKVEGL FPTKDDFKRMIPAVLRGTSLGAALGILPGGGALLAAFAAYTVEKKTKLQPGEVPFGQGNI RGVAAPESANNAGSQTSFIPLLTLGIPPNAVMALMVGAMTIHNIQPGPQVMTSNPELFWG LIASMWIGNAMLIVLNLPLIGIWIKLLTVPYRWLFPSIVLFCAVGVYSTNNNTFDIWMVG IFGLIGYIFHKLGTEPAPLLLGFILGPMMEENLRRALLLSRGDWSVFVTRPLSAGLLAAA ALLLIIVLLPAVKNKREEAFVED
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server